Vanguard Group’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $369K | Sell |
|
|||||
|
2018
Q4 | $266K | Sell |
|
|||||
|
2018
Q3 | $2.14M | Buy |
|
|||||
|
2018
Q2 | $2.31M | Sell |
|
|||||
|
2018
Q1 | $3.19M | Buy |
|
|||||
|
2017
Q4 | $4.09M | Sell |
|
|||||
|
2017
Q3 | $4.64M | Buy |
|
|||||
|
2017
Q2 | $3.31M | Buy |
|
|||||
|
2017
Q1 | $8.71M | Buy |
|
|||||
|
2016
Q4 | $6.94M | Buy |
|
|||||
|
2016
Q3 | $9.28M | Buy |
|
|||||
|
2016
Q2 | $7.78M | Buy |
|
|||||
|
2016
Q1 | $6.08M | Buy |
|
|||||
|
2015
Q4 | $9.82M | Buy |
|
|||||
|
2015
Q3 | $7.14M | Buy |
|
|||||
|
2015
Q2 | $8.74M | Buy |
|
|||||
|
2015
Q1 | $9.35M | Buy |
|
|||||
|
2014
Q4 | $6.12M | Buy |
|
|||||
|
2014
Q3 | $4.56M | Buy |
|
|||||
|
2014
Q2 | $4.12M | Buy |
|
|||||
|
2014
Q1 | $5.07M | Buy |
|
|||||
|
2013
Q4 | $3.1M | Buy |
|
|||||
|
2013
Q3 | $1.49M | Buy |
|